English:The Cell Cycle and Cancer
The Cell Cycle and Cancer
Introduction
The cell cycle is the controlled sequence of events through which a cell grows, copies its DNA, and divides. Cancer develops when genetic and cellular control systems are altered so that cells can survive, grow, and divide in ways that no longer serve the organism. In this aiMOOC, you will connect the normal logic of the cell cycle with the molecular changes that can contribute to cancer. The course is designed for Grades 11–13 and is suitable for advanced secondary biology, AP or IB-style courses, introductory college biology, and vocational health-science education.
You will learn to explain the phases of the cell cycle, distinguish checkpoints from phases, model the action of cyclins and cyclin-dependent kinases, interpret the roles of p53 and Rb, and compare proto-oncogenes, oncogenes, tumor suppressor genes, and DNA-repair genes. You will also examine how cancer cells can acquire abilities such as resistance to cell death, sustained proliferation, angiogenesis, invasion, and metastasis.
This course is for biology learning. It does not provide personal medical diagnosis or treatment advice.
.jpg)
The image above is a scanning electron micrograph of a breast cancer cell. A cancer cell is still a human cell, but its regulation, genome, signaling, and interactions with surrounding tissues may differ strongly from those of healthy cells.
The video gives a secondary-school overview of the cell cycle, checkpoints, regulators, apoptosis, and cancer. As you watch, write down one statement about a normal cell-cycle control and one statement about what can happen when that control fails.
Learning Goals
By the end of this aiMOOC, you should be able to:
| Area | What you should be able to do |
|---|---|
| Cell-cycle structure | Explain G1, S, G2, M, cytokinesis, and G0, and connect each stage with its biological purpose. |
| Molecular regulation | Explain how cyclins, CDKs, checkpoints, p53, p21, Rb, E2F, and the spindle checkpoint help coordinate cell division. |
| Cancer genetics | Distinguish activating changes in proto-oncogenes from loss-of-function changes in tumor suppressor genes and defects in DNA-repair genes. |
| Cancer progression | Explain why uncontrolled proliferation alone does not describe the full biology of cancer, and relate mutation, selection, angiogenesis, invasion, and metastasis. |
| Evidence and data | Interpret cell-count data, mitotic indices, pathway diagrams, pedigrees, and simplified mutation profiles. |
| Transfer | Use cell-cycle knowledge to reason about cancer prevention, diagnosis, research, and treatments without oversimplifying individual cases. |
The Normal Cell Cycle
Why Cells Divide
In multicellular organisms, cell division supports growth, development, tissue maintenance, wound repair, and replacement of cells that are lost. Division must be coordinated with cell size, nutrient availability, extracellular signals, DNA integrity, and chromosome attachment. A cell that divides too early, with damaged DNA, or with incorrectly attached chromosomes can pass problems to its daughter cells.
Many differentiated cells divide only when needed. Some cells can leave the active cycle and enter a reversible or long-term non-dividing state called G0. The exact behavior depends on cell type and physiological context.
Interphase: G1, S, and G2
G1 phase is a period of growth, biosynthesis, and response to extracellular signals. The cell builds proteins and organelles and assesses whether conditions favor another round of division.
S phase is the phase of DNA synthesis. Each chromosome is replicated so that, after replication, it consists of two sister chromatids joined by cohesin complexes. DNA replication must be accurate enough to preserve genetic information, while repair systems correct many kinds of damage and replication errors.
G2 phase follows DNA replication. The cell continues to grow, prepares components needed for mitosis, and monitors whether DNA replication has been completed and whether serious damage remains.
The diagram shows the common organization of the cell cycle. Notice that interphase includes G1, S, and G2; it is not a resting phase. Cells are metabolically active throughout interphase.
Use the video to check whether you can distinguish the purpose of each phase from the visible events of mitosis.
M Phase: Mitosis and Cytokinesis
During mitosis, duplicated chromosomes are segregated into two nuclei. During cytokinesis, the cytoplasm is divided so that two daughter cells form.
In prophase, chromosomes condense and the mitotic spindle begins to form. In prometaphase, the nuclear envelope breaks down and spindle microtubules can interact with chromosome kinetochores. In metaphase, chromosomes align so that sister kinetochores are attached to opposite spindle poles. In anaphase, sister chromatids separate and move toward opposite poles. In telophase, new nuclear envelopes form around the separated chromosome sets. Cytokinesis completes physical cell division.
The sequence is useful, but the central idea is not memorizing labels. The biological problem is accurate chromosome segregation. The cell must copy its genome once and distribute one complete copy to each daughter cell.
While watching, identify one mechanical event, one regulatory event, and one example of what can happen when regulation fails.
Cell-Cycle Control
Checkpoints as Decision Systems
A checkpoint is not simply a place on a diagram. It is a control system that delays progression when essential conditions have not been met. Three major checkpoint contexts are especially important.
The G1 or G1/S checkpoint integrates growth signals, nutrients, cell size, and DNA-damage information before the cell commits to DNA replication.
The G2/M checkpoint prevents entry into mitosis when DNA replication is incomplete or when serious DNA damage remains.
The spindle-assembly checkpoint acts during mitosis and prevents chromosome separation until kinetochores are properly attached to the spindle.
Checkpoints do not guarantee perfection. They reduce the chance that errors are passed on. Cancer can arise through many routes, and the failure of one control can increase the probability that further changes accumulate.
Cyclins and Cyclin-Dependent Kinases
Cyclin-dependent kinases, or CDKs, are protein kinases whose activities are regulated partly by binding to cyclins. Cyclin concentrations rise and fall during the cycle, helping to activate different CDK complexes at different times. Active cyclin-CDK complexes phosphorylate target proteins and can trigger transitions such as entry into S phase or mitosis.
CDK activity is also controlled by phosphorylation, dephosphorylation, inhibitory proteins, gene expression, and targeted protein degradation. The result is a network of molecular switches rather than a single on-off button.
A useful model is to think of CDKs as engines that can drive transitions and cyclins as time-dependent activating partners. The model is incomplete by itself, because inhibitory proteins and checkpoint pathways can still stop the system.
After viewing, explain why a cell-cycle control system needs both positive regulators and negative regulators.
The Rb and E2F Control Point
The Rb protein helps restrain entry into S phase. In simplified form, Rb can bind the transcription factor E2F and reduce expression of genes needed for DNA replication. When appropriate growth signals activate cyclin D-CDK4 or cyclin D-CDK6 complexes, Rb becomes phosphorylated. This reduces its inhibition of E2F and helps cells progress toward S phase.
This pathway illustrates a general principle: a normal growth-promoting signal does not directly mean "divide now." It is processed through regulatory networks that include brakes, feedback loops, and checkpoints. Mutations that remove Rb function, overactivate upstream growth signals, or increase cyclin-CDK activity can shift this balance toward inappropriate proliferation.
p53, p21, DNA Damage, and Apoptosis
The protein p53 is a transcription factor and tumor suppressor that responds to several forms of cellular stress, including DNA damage. Activated p53 can increase expression of p21, a CDK inhibitor. Increased p21 can slow or stop cell-cycle progression, giving the cell time to repair damage.
If damage is too severe, p53 can contribute to pathways that lead to apoptosis, a regulated form of cell death. This is important because a multicellular organism benefits when a dangerously damaged cell is removed rather than allowed to keep dividing.
The p53 network has many inputs and outputs. For Grade 11–13 reasoning, focus on the logic: damage can activate a sensor-response network; the response can pause the cycle, promote repair, or help trigger cell death; loss of this control can allow damaged genomes to persist.
From Normal Regulation to Cancer
Cancer Is a Genetic and Evolutionary Process
Cancer is a large group of diseases in which cells acquire changes that allow abnormal growth and, in malignant cancers, invasion or spread. The relevant genetic changes can arise from errors during cell division, from DNA damage caused by environmental exposures, or from inherited variants. Most cancer-causing changes are acquired during a person's lifetime, but inherited variants can alter risk.
A mutation is not automatically a cancer-causing event. Most mutations do not transform a normal cell into a cancer cell. Cancer usually develops through the accumulation and selection of multiple changes that alter cellular behavior. Within a growing tumor, different subclones may carry different combinations of mutations. This genetic diversity can affect progression and treatment response.
Proto-Oncogenes and Oncogenes
A proto-oncogene is a normal gene that helps regulate growth, survival, or division. If a proto-oncogene becomes abnormally active through mutation, amplification, or another regulatory change, it can become an oncogene. Oncogenes often act like a growth signal that is stuck in an active state.
Examples include altered forms of RAS-family signaling proteins, increased MYC activity, or excessive activity of certain growth-factor receptors or cyclins. The specific mechanism matters: an oncogene can influence signaling, transcription, metabolism, survival, or cell-cycle entry.
Tumor Suppressor Genes and the Two-Hit Idea
Tumor suppressor genes encode proteins that restrain proliferation, maintain genome integrity, promote repair, or help remove damaged cells. Important examples include TP53, RB1, and APC.
For some tumor suppressor genes, loss of both functional gene copies in a cell is a common route to loss of function. This idea is captured by the classic two-hit model developed from retinoblastoma. The model is useful but not universal: some tumor suppressors show dosage effects, dominant-negative behavior, or more complex regulation.
In the analogy, the braking system becomes progressively compromised as functional tumor-suppressor activity is lost.
DNA-Repair Genes and Genome Stability
DNA-repair genes are sometimes called genome-maintenance or caretaker genes. Their products help correct DNA damage and replication errors. When repair pathways are impaired, mutations and chromosome abnormalities can accumulate more rapidly.
BRCA1 and BRCA2, for example, participate in accurate repair of double-strand DNA breaks by homologous recombination. Inherited pathogenic variants in these genes can increase the risk of certain cancers, but the presence of a risk variant does not mean that cancer is inevitable.
Use the diagram to compare two different routes to altered growth control: too much activity from a growth-promoting gene and too little activity from a growth-restraining gene.
A Systems View: Several Controls Can Fail
A useful way to reason about cancer is to imagine a regulated network with accelerators, brakes, repair systems, and quality-control checkpoints. Cancer can develop when multiple parts of this network are altered. One cell might gain an activating RAS mutation, another change may weaken p53-dependent responses, and a later change may increase survival or invasion. Different cancers reach malignant behavior through different combinations.
This explains why "cancer" is not one molecular disease and why two tumors from the same organ can differ genetically. It also explains why treatments increasingly use molecular information about a tumor rather than only its location.
Tumor Growth, Angiogenesis, Invasion, and Metastasis
From Abnormal Clone to Tumor
A clone of cells with a growth advantage can expand over time. A benign tumor remains localized and does not invade surrounding tissue in the way a malignant tumor does. A malignant tumor can infiltrate nearby tissue, interact with the immune system and extracellular matrix, and sometimes spread to distant sites.
Cell-cycle deregulation is central to tumor growth, but a successful malignant cancer usually needs more than rapid division. Cancer cells must also survive stresses, acquire resources, and interact with surrounding cells.
Angiogenesis and the Tumor Microenvironment
As a solid tumor enlarges, diffusion alone becomes insufficient to supply oxygen and nutrients to all tumor cells. Tumors can promote angiogenesis, the formation of new blood vessels, by changing the balance of signaling molecules such as vascular endothelial growth factor.
The tumor microenvironment includes cancer cells, immune cells, fibroblasts, extracellular matrix, signaling molecules, and blood vessels. These components can influence cancer growth, invasion, and response to treatment.
The image shows the concept of an angiogenic switch. Ask yourself why a new blood supply could increase both tumor growth and opportunities for cancer cells to enter circulation.
Invasion and Metastasis
Metastasis is the spread of cancer cells from a primary tumor to distant sites where they form new tumors. It is a multistep process. Cells must detach or alter their local interactions, invade surrounding tissue, enter blood or lymphatic vessels, survive transport, leave the circulation, and establish growth in a new tissue.
Most cells that enter the circulation do not successfully form metastases. Metastasis is therefore not simply "cells moving through blood"; it requires a sequence of difficult biological steps.
The image represents one stage of the metastatic process: cancer cells entering the bloodstream from a primary tumor.
Cell-Cycle Knowledge and Cancer Treatment
Cancer treatment depends on the cancer type, stage, molecular features, patient health, and many other clinical factors. This section explains biological principles, not individual treatment recommendations.
Chemotherapy includes drugs that kill cancer cells or stop their growth. Many chemotherapy drugs affect DNA replication, mitosis, or other processes that are especially important in rapidly dividing cells. Because some healthy tissues also contain rapidly dividing cells, treatment can affect healthy cells too.
Radiation therapy uses high doses of ionizing radiation to damage DNA in targeted tissue. Cells with damage they cannot repair may stop dividing or die.
Targeted therapy acts on specific molecules or pathways that cancer cells depend on. Some drugs inhibit kinases. CDK4/6 inhibitors, for example, can block a cell-cycle transition in particular cancer contexts.
Immunotherapy helps the immune system recognize or attack cancer cells more effectively. It acts through immune biology rather than simply "speeding up" cell division or death.
Cancer cells can evolve resistance. A treatment may remove sensitive cells while a resistant subclone survives and expands. This is another reason evolutionary thinking is useful in cancer biology.
After the video, write a short explanation of why the phrase "cancer is uncontrolled mitosis" is useful as a first approximation but incomplete as a full description.
Working with Cell-Cycle Data
Mitotic Index
The mitotic index is the fraction of observed cells that are in mitosis at a particular time. If you count 200 cells and 30 are visibly in mitosis, the mitotic index is 30 divided by 200, or 0.15. A higher mitotic index can indicate a larger proportion of cells undergoing mitosis, but interpretation depends on cell type, sampling, and how long cells spend in mitosis.
A high mitotic index does not by itself prove that a tissue is cancerous. Normal tissues with active growth or repair can also contain many dividing cells.
Inferring Phase Duration from Cell Counts
If a large population of asynchronously cycling cells is sampled randomly and the cycle is approximately stable, the fraction of cells observed in a phase can be used to estimate the fraction of cycle time spent in that phase. For example, if 60 percent of cells are in G1, a simple model predicts that the average cell spends about 60 percent of its cycling time in G1.
This inference depends on assumptions. Cells must be sampled without bias, the population should be near steady state, and different phases should not have strongly different survival probabilities.
Interpreting Mutation Profiles
A mutation table can contain many changes. To decide which changes are most relevant to cell-cycle control, ask:
- Does the gene normally promote proliferation, restrain proliferation, repair DNA, or regulate apoptosis?
- Is the observed change likely to increase activity, decrease activity, or alter regulation?
- Could the change affect G1/S entry, DNA-damage responses, mitosis, survival, or genome stability?
- Does the evidence show association only, or is there functional evidence that the mutation changes cell behavior?
These questions help you avoid the common mistake of treating every detected mutation as a driver of cancer.
Scientific Sources and Further Learning
The following open or freely accessible resources support and extend the biology in this course.
- OpenStax Biology 2e: Cancer and the Cell Cycle: An open textbook section on cell-cycle regulation, proto-oncogenes, oncogenes, and tumor suppressors.
- National Cancer Institute: What Is Cancer?: A clear overview of cancer genetics, tumor growth, and metastasis.
- HHMI BioInteractive: The Eukaryotic Cell Cycle and Cancer: An interactive resource designed for high school, AP or IB, and college learners.
- National Cancer Institute: Types of Cancer Treatment: An overview of chemotherapy, radiation therapy, targeted therapy, immunotherapy, surgery, and other approaches.
Interactive Tasks
Quiz: Test Your Knowledge
Which phase is responsible for replicating the cell's DNA? (S phase) (!G1 phase) (!G2 phase) (!M phase)
What is the main function of a cell-cycle checkpoint? (To delay progression when required conditions are not met) (!To copy every chromosome) (!To produce ATP for mitosis) (!To make all cells divide faster)
Which molecules form key complexes that drive cell-cycle transitions? (Cyclins and cyclin dependent kinases) (!Antibodies and antigens) (!Ribosomes and lysosomes) (!Collagen and keratin)
What can p21 do after it is induced by p53? (Inhibit cyclin dependent kinase activity) (!Activate every oncogene) (!Separate sister chromatids) (!Build spindle microtubules)
Which statement best describes a proto-oncogene? (A normal gene that can become cancer promoting when abnormally activated) (!A gene found only in cancer cells) (!A gene that always repairs DNA) (!A gene that destroys all tumors)
Which type of gene normally restrains cell growth or protects against inappropriate division? (Tumor suppressor gene) (!Oncogene) (!Ribosomal gene) (!Transfer RNA gene)
What is metastasis? (The spread of cancer cells to distant sites where new tumors can form) (!The normal copying of DNA) (!The alignment of chromosomes at metaphase) (!The repair of a single DNA base)
Why can loss of DNA repair increase cancer risk? (It can allow mutations and chromosome changes to accumulate) (!It guarantees that every cell becomes malignant) (!It prevents all cell division) (!It makes chromosomes disappear)
What does the spindle assembly checkpoint monitor? (Proper chromosome attachment before separation) (!Whether DNA replication starts in G1) (!Whether a tumor has blood vessels) (!Whether a gene is inherited)
Why is rapid cell division alone an incomplete definition of cancer? (Cancer also involves changes in survival invasion signaling and tissue interactions) (!Cancer never involves cell division) (!Only viruses can cause cancer) (!Every rapidly dividing normal tissue is malignant)
Memory Game
| Cyclin | Regulatory protein whose abundance can vary through the cell cycle |
| Checkpoint | Control system that can delay progression when conditions are unsuitable |
| Oncogene | Abnormally activated growth promoting gene |
| Apoptosis | Regulated process of cell death |
| Metastasis | Spread of malignant cells to distant tissues |
| Angiogenesis | Formation of new blood vessels |
| Cytokinesis | Physical division of the cytoplasm |
Drag and Drop
| Match the correct terms. | Topic |
|---|---|
| DNA replication | S phase |
| Growth and signal integration | G1 phase |
| Preparation for mitosis | G2 phase |
| Chromosome segregation | Mitosis |
| Regulated cell death | Apoptosis |
Match each biological process with the phase or concept that best describes it.
Crossword Puzzle
| Checkpoint | What control system can delay cell-cycle progression when a requirement has not been met? |
| Cyclin | What regulatory protein can rise and fall in concentration during the cell cycle? |
| Apoptosis | What regulated form of cell death can remove severely damaged cells? |
| Oncogene | What is a cancer-promoting form of an abnormally activated proto-oncogene? |
| Metastasis | What process describes cancer spreading to distant parts of the body? |
| Cytokinesis | What process physically divides the cytoplasm after nuclear division? |
LearningApps
Cloze Text
Open-Ended Tasks
Easy
- Cell cycle model: Create a labeled one-page diagram of G1, S, G2, M, cytokinesis, and G0. Add one sentence explaining the purpose of each stage.
- Mitosis photo guide: Produce a visual guide that helps another learner identify prophase, metaphase, anaphase, and telophase in microscope images.
- Cancer vocabulary podcast: Record a three-minute audio explanation that correctly uses the terms mutation, checkpoint, oncogene, tumor suppressor, apoptosis, and metastasis.
- Checkpoint interview: Interview a classmate after they study this course and ask them to explain why checkpoints are useful. Summarize which ideas were clear and which were confusing.
Standard
- Mitotic index investigation: Use prepared slides, approved microscope images, or a teacher-provided dataset to count cells in mitosis, calculate a mitotic index, and discuss the limits of your result.
- Cell-cycle regulator infographic: Design an infographic that connects cyclin D, CDK4 or CDK6, Rb, E2F, p53, and p21. Use arrows and inhibition symbols to show causal relationships.
- Cancer gene case study: Choose one gene such as TP53, RB1, APC, KRAS, BRCA1, or BRCA2 and create a two-page case study explaining its normal function and how alteration can contribute to cancer.
- Treatment mechanism video: Produce a five-minute explainer comparing how chemotherapy, radiation therapy, targeted therapy, and immunotherapy connect to cell biology.
Advanced
- Mutation profile analysis: Analyze a teacher-provided tumor mutation table and classify candidate changes as affecting growth promotion, growth restraint, DNA repair, apoptosis, or another pathway. Defend your classifications with evidence.
- Cancer evolution simulation: Build a paper, spreadsheet, or coding simulation in which cell clones acquire different growth rates and treatment sensitivities. Explain how selection can change clone frequencies over time.
- Research laboratory visit: Visit a university laboratory, pathology department, cancer research center, or virtual laboratory tour and prepare a report on one method used to study proliferation, DNA damage, or tumor biology.
- Mini research proposal: Write a research proposal with a testable question, hypothesis, variables, method, expected results, limitations, and ethical considerations for investigating a cell-cycle regulator in cancer cells.
Learning Assessment
- Pathway reasoning: Explain how an activating change in a growth-signaling pathway and loss of a tumor suppressor could cooperate to increase proliferation. Use at least two named molecules in your explanation.
- Checkpoint failure scenario: A cell has severe DNA damage but still enters S phase. Propose two molecular defects that could explain this behavior and predict one consequence for genome stability.
- Data interpretation: Compare two cell populations with different mitotic indices and explain at least three reasons why the population with the higher index might not necessarily be malignant.
- Treatment transfer: Choose one treatment class and connect its mechanism to a specific cell-cycle or survival process. Then explain why healthy tissue can also be affected.
- Evolution and resistance: Use a clonal-selection model to explain how a rare resistant cell can become common during treatment even if the treatment initially shrinks a tumor.
- Model evaluation: Evaluate the statement "cancer is uncontrolled mitosis." State what the model captures correctly, what it leaves out, and how you would improve it for an advanced biology class.
Evidence of Learning
- Knowledge: You can accurately describe cell-cycle phases, checkpoints, cyclin-CDK regulation, p53 and Rb pathways, cancer-gene classes, angiogenesis, invasion, and metastasis.
- Skills: You can interpret phase diagrams, calculate and evaluate mitotic indices, analyze simplified molecular pathways, distinguish correlation from mechanism, and reason from genetic evidence.
- Products: You can produce scientifically accurate diagrams, infographics, videos, reports, models, simulations, or research proposals that communicate cell-cycle and cancer biology clearly.
- Transfer: You can apply cell-cycle concepts to unfamiliar mutation profiles, treatment mechanisms, experimental results, and claims about cancer while identifying assumptions and limitations.
- Scientific communication: You can use terms precisely, cite trustworthy sources, explain uncertainty, and avoid treating all cancers or all mutations as biologically identical.
OERs on the Topic
For additional open learning, use OpenStax Biology 2e and the HHMI BioInteractive cell-cycle and cancer interactive.
Linked Learning Areas
